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1. Introduction 
Data on the reversible dissociation of luteinizing 
hormone into subunits ((II and 0) as a function of pH 
strongly suggest hat ionic bonds between carboxyl- 
and amino-groups are involved in the maintenance of 
the quaternary structure of the hormone [ 11. In order 
to test this possibility, the study of the modification 
of carboxyl-groups with water-soluble carbodiimide 
in the absence and in the presence of ammonium 
chloride was undertaken. When ammonium chloride 
is present, the reaction leads to the formation of 
carboxamido-groups [2]. In its absence amino-groups 
of proteins can react with unstable 0-acyl isourea 
intermediates resulting from the derivatization of 
carboxyl-groups with carbodiimide. This leads to the 
formation of intramolecular amide bridges provided 
that carboxyl- and amino-groups are situated close 
together in the native conformation [3]. 
2. Materials and methods 
Porcine luteinizing hormone (pLH) was purified as 
previously described [4]. The incubations of the 
hormone with 1 ethyl, 3 (3 dimethylaminopropyl) 
cerbodimiimide (EDC) (Ott Chemical Co.) were carried 
out in water at room temperature for 1 hr [5]. The 
pH was maintained at 4.75 with the aid of a Radio- 
meter automatic titrator. When present, ammonium 
chloride (Merck) was at a concentration of 5.5 M. 
EDC was either 0.1 M or 0.01 M. The hormone was 
2 mg per ml when ammonium chloride was present. 
In the absence of the nucleophile the protein concen- 
tration was lowered to 0.1 or 0.5 mg per ml in order 
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to avoid polymerization and to favour intramolecular 
crosslinking. The reactions were stopped either by 
deep-freezing followed by lyophilization or by exten- 
sive dialysis against 10e3 N HCl. In one instance, the 
reaction was stopped by the addition of sodium acetate 
to a final concentration of 1 M. 
Gel filtrations were on Sephadex G- 100 (Phar- 
macia) columns at 4°C. Amino acid analyses were 
done after HCl hydrolysis with a Beckman 121 
Amino Acid Analyzer [6]. Molecular weight estima- 
tions by sodium dodecyl sulfate (SDS)-poly-acrylami- 
de gel electrophoresis were as previously described 
[7] on 10% polyacrylamide gels. Biological activities 
were measured by the ovarian ascorbic acid deple- 
tion test [S] with NIH-LH S17 as standard. 
Immunological activity was determined as pre- 
viously described [9] by a double antibody radio- 
immunoassay using pLH ’ 31 I as tracer and rabbit 
pLH antiserum at a final dilution of 1: 600 000. 
Complete dose-response curves were run with 2 
replicates at each dose level. 
Circular dichroism (CD) spectra were recorded on 
a JASCO Model ORD/UV-5 spectropolarimeter as 
previously described [lo] . 
3. Results 
Fig. 1 A shows that after amidation of carboxyl- 
groups of pLH by 0.1 M EDC and 5.5 M ammonium 
chloride, the elution volume on Sephadex G- 100 of 
the hormone corresponds to that of its subunits 
(I’,/ l/e = 2.0) while the hormone incubated with 
ammonium chloride alone still exhibits a normal 
elution volume (Ve/ Ve = 1.7). 
North-Holland Publishing Company - Amsterdam 
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Fig. 1. Gel filtration of porcine LH derivatives. Sephadex 
G-100 column (1.7 X 95 cm), with 0.05 M ammonium 
bicarbonate (pH 8.2) buffer. Flow rate 4 ml.hr- ’ cm-‘. 
Dotted lines indicate the respective lution positions of 
native porcine LH (1.7) and of its subunits (2.0). A) porcine 
LH treated with 0.1 M EDC and 5.5. M NH,Cl (e----+-e); 
porcine LH treated by 5.5 M NH, Cl alone as reference 
(o--o--o). B) Porcine LH treated with 0.1 M EDC (left); 
Material from the shaded area was incubated with 8 M urea, 
lo-* N HCI and rechromatographed on the same column 
(right). C) Porcine LH treated with 0.01 M EDC (left); 
Material from the shaded area was incubated with 8 M urea 
10-a N HCI and rechromatographed on the same column 
(right). 
pLH treated with 0.1 M EDC alone was dialyzed 
against 1 0e3N HCl and lyophilized. On Sephadex 
G-100 this product exhibits a major peak (shaded on 
fig, 1 B) with an elution volume identical to that of 
the native hormone. Material from this fraction was 
incubated overnight in 8 M urea at pH 2.0 and sub- 
mitted to a second gel filtration on the same column 
(fig. 1, B right). A single symmetrical peak is ob- 
Table 1 
Properties of native luteinizing hormone and of its 
carbodiimidetreated erivatives 
Treatments’ 
ve/ vo Molecular Biological 
‘e/ ‘0 after weights activity’ 
8 M urea 
1.7 2.0 15 700 
19 100 
100% 
5.5 M NH,Cl 1.7 N.D N.D 
0.1 M EDC + 5.5 M NH,Cl 2.0 N.D < 1% 
0.1 M EDC 1.7 1.7 27 500 < 1% 
0.01 M EDC stopped by 
dialysis: 
expt 1 1.7 1.7 29 000 100% 
expt 2 1.7 1.7 70% 
0.01 M EDC stopped by 
quenching with 1 M sodium 
acetate 1.7 1.7 < 1% 
N.D Not determined. 
1 See Materials and methods. 
I See fig. 1. 
s Estimation by sodium dodecyl sulfate-gel electrophorez. 
4 Percentage of remaining activity. 
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Fig. 2. Radioimmunological activity of porcine LH derivatives. Rabbit pLH-antiserum is used at a final dilution of 1:600 000 
with [Is’ I]pLH as tracer. Duplicates were made at each dose level. 
tained which is still eluted at the elution volume of 
the native hormone. 
Similar results were obtained with porcine LH 
treated with 0.01 M EDC except that the proportion 
of material eluted at the position of the subunits 
is greater with consequently less material recovered in 
front of the major peak. In both cases the yield of 
protein with the the elution volume of native LH 
after the second run on Sephadex G-100 (fig. 1 B 
and C) amounted of 45-6% of starting material. 
The amino acid composition of EDC-treated 
hormones is identical to that of native LH. In parti- 
cular the tyrosine content is unaffected by the 
treatment. As the 0-aryl isourea derivative of tyrosine 
is stable to acid hydrolysis [ 1 l] it appears that the 
tyrosine residues of the hormone had not been 
modified by EDC. 
Estimations of molecular weight and biological 
activities of LH derivatives are shown in table 1. 
It is shown in fig. 2 that the immunological 
dose-response curves obtained with the native por- 
cine hormone and the materials treated with 0.01 M 
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EDC are similar while the 0.1 M EDC-treated hormone 
exhibits a significantly different pattern, with a five- 
fold decreased affinity to pLH specific antibodies. 
In the 320-240 nm region, native hormone, 0.1 M 
EDC-treated and 0.01 M EDC-treated LH exhibit 
exactly the same CD spectrum with a broad negative 
maximum ([e] M = -33 X lo3 deg. cm2 dmol-‘) 
at 280 nm [lo] . In contrast, 0.1 M EDC-treated LH 
differs from native and 0.01 M EDC-treated hormones, 
in the 200-250 nm region of its CD spectrum. The 
ellipticity of this derivative at 2 12 nm is greatly 
decreased compared to native LH [lo] while an 
important negative band appears below 2 10 nm. As 
the dynode voltage rose to exceedingly high values 
(> 700 V) for wavelengths inferior to 210 nm, the 
exact position of this band could not be determined. 
4. Discussion 
This work has shown that modification of carboxyl- 
groups of the hormone to carboxamido-groups leads 
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to its dissociation into subunits. As the modification 
involves the replacement of a negatively charged 
group by a neutral one, this suggests that the dissoci- 
ation is due to the breakage of electrostatic bond(s) 
between carboxyl-group(s) and positively charged 
group(s). However, this result does not imply that 
these groups are located on different subunits. 
If carboxyl-amino pairs are indeed involved in the 
maintenance of the quaternary structure, in the absen- 
ce of added nucleophile the amino-group is expect- 
ed to attack the nearby active 0-acyl isourea deriva- 
tive formed by the treatment with EDC. Indeed, 
from the gel filtration patterns, it appears that, in 
contrast to the native hormone, EDC-treated hor- 
mones do not dissociate into subunits upon treat- 
ment with acidic 8 M urea. This is clearly confirmed 
by SDS-gel electrophoresis indicating that covalent 
linkage has occurred between the two subunits. 
The biological activity of undissociable luteinizing 
hormones prepared with 0.1 M EDC and 0.01 M 
EDC respectively clearly differ (table 1). While the 
latter is still fully active the former is completely 
inactivated. This drastic difference in potency can be 
related to a difference in the number of amide 
bridges in the two derivatives. The fl subunit of pLH 
contains no free amino-groups [ 121, thus it is ob- 
vious that intersubunit amide bridge(s) involve(s) 
carboxyl-group(s) from this subunit and amino-group(s) 
from the cu subunit [ 131. The fact that an LH deri- 
vative with covalently-linked subunits is biologically 
active shows that after binding with its receptor the 
hormone does not dissociate to ellicit its biological 
function. 
As with its biological activity, the immunological 
reactivity of LH is markedly decreased after treatment 
with 0.1 M EDC and remains intact with 0.01 M EDC. 
‘CD spectra of native pLH and of the two undisso- 
ciable derivatives in the 320-240 nm region show no 
difference. It is thought that the broad negative 
aromatic Cotton effect observed at 280 nm in the 
spectrum of native pLH is due to shielding of tyrosyl 
residues as a consequence of the association of the 
subunits [ 10,14,15] . Thus, the establishment of at 
least one covalent linkage in the binding area of the 
subunits apparently does not disturb the status of 
these tyrosyl residues. In the 200-250 nm region, 
the CD spectra of native LH and of the active 
undissociable hormone are not significantly different. 
In contrast, that of the inactive derivative is different 
as its negative maximum is enhanced and shifted from 
212-214 nm to a wavelength under 210 nm. It is 
impossible to draw precise conclusions from these 
observations but, together with biological and immu- 
nological data, they suggest an important effect of 
0.1 M EDC on the 3-dimensional structure of pLH. 
The loss of biological and immunological activities 
of 0.1 M EDC-treated hormone might be due to a loss 
of ‘flexibility’ of the molecule arising from the esta- 
blishment of additional covalent bridges. This rigid- 
ity of the hormone could prevent the binding of 
the molecule to its receptor and its antibodies. 
Nevertheless, disappearence of amino- or carboxyl- 
groups essential for biological function cannot be 
excluded. 
When the reaction with 0.01 M EDC is stopped 
with sodium acetate, the biological activity of the 
derivative is completely destroyed and cannot be 
restored by treatment with 0.1 M hydroxylamine 
(table 1). In contrast immunological reactivity of 
this derivative is comparable to those of native and 
active undissociable hormones (fig. 2). This loss of 
biological activity is attributed to the acetylation of 
an essential lysine residue of the (11 subunit. This 
hypothesis is in agreement with the recent data of De 
LaLlosaetal. [16]. 
The location of the amide bridge(s) of the active 
undissociable hormone is under study and should 
provide information concerning the binding area 
between subnits. It has been postulated [ 15,17,18] 
that binding area between subunits of both luteiniz- 
ing hormone and thyrotropin are similar. The fact 
that we have recently succeeded in the preparation of 
undissociable thyroid-stimulating hormone using 
EDC supports this view. Lastly, as active undissociable 
hormone exhibits immunological activity similar to 
that of native hormone it may be of interest to use 
this derivative in the purification of specific antibody 
to dimeric hormone by affinity chromatography. 
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